Branchiootorenal (BOR) syndrome is a rare autosomal dominant inherited disease with a prevalence of approximately 1 in 40,000 newborns. This disease is characterized by hearing loss, preauricular pits, branchial fistulas or cysts, and renal dysplasia. We discovered a case of BOR syndrome in a premature 2-week-old female infant with a gestational age of 32 weeks and two days. She and her family had major symptoms and a family history of BOR. BOR syndrome was confirmed by whole-genome sequencing and structural variant calling, which revealed an exon 5-6 deletion. The infant had recurrent sleep and feeding cyanosis with second branchial anomalies. Via videofluoroscopic swallowing study and a modified barium swallow test, penetration into the vocal cords was observed before and during swallowing when bottle feeding. This is the first report of a preterm infant early diagnosed with BOR syndrome in which deletion margin was accurately identified by whole-genome sequencing and structural variant calling in Republic of Korea.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856635PMC
http://dx.doi.org/10.3390/children10010076DOI Listing

Publication Analysis

Top Keywords

bor syndrome
20
whole-genome sequencing
12
sequencing structural
12
structural variant
12
variant calling
12
preterm infant
8
diagnosed bor
8
syndrome confirmed
8
bor
6
syndrome
5

Similar Publications

A 17 year old male patient presented with bilateral preauricular sinus, right sided second branchial cleft sinus and bilateral hearing deficit. He has previous history of right congenital cataract surgery and right dacryocystorhinostomy at the age of 8 year. He was operated for branchial sinus.

View Article and Find Full Text PDF
Article Synopsis
  • Syndromic hearing loss (SHL) involves diverse genetic causes, with over 400 types identified, primarily following an autosomal dominant inheritance pattern.
  • A study analyzed 14 patients (ages 5-78 months) with various syndromes associated with SHL, discovering ten new genetic variants and confirming cases of well-known syndromes like Waardenburg and CHARGE.
  • Results suggest that combining neonatal hearing screenings with whole exome sequencing can effectively diagnose SHL early, highlighting the need for thorough monitoring of patients due to the complexity and variability of SHL symptoms.
View Article and Find Full Text PDF
Article Synopsis
  • Branchio-oto-renal (BOR) spectrum disorders involve genetic changes in the EYA1 gene, making prenatal detection challenging due to varied symptoms.
  • A new pathogenic variant in the EYA1 gene was identified during a study of pregnant women who underwent fetal whole-exome sequencing, alongside a review of previous cases.
  • The findings highlight that subtle manifestations complicate prenatal ultrasounds, with particular emphasis on amniotic fluid and cardiac issues, and suggest that certain genetic markers could enhance early diagnosis of these disorders.
View Article and Find Full Text PDF

Incoherent collective cell chemotaxis underlies organ dysmorphia in a model of branchio-oto-renal syndrome.

MicroPubl Biol

September 2024

Department of Neurophysiology and Developmental Neurobiology,, Instituto de Neurobiología, Universidad Nacional Autónoma de México, Juriquilla, México.

Article Synopsis
  • Mutations in the gene responsible for branchio-oto-renal syndrome (BOR) cause multi-organ malformations in humans and similar effects in animal models.
  • Researchers studied the zebrafish posterior lateral-line primordium to investigate the role of the Eya1 gene in organ development.
  • Their findings revealed that the loss of Eya1 reduces specific chemokine receptor expression, disrupting cell movement and leading to abnormal formation of the lateral line, which suggests that issues with cell movement contribute to organ malformations in BOR.
View Article and Find Full Text PDF

Introduction: Vitamin-K antagonists (VKA) are considered the first-line anticoagulants for thrombotic antiphospholipid syndrome (TAPS), particularly with triple positivity or arterial events. However, thrombotic recurrence remains high despite anticoagulation and other clinical issues may arise. Long-term parenteral anticoagulants may therefore be considered, however little is known about the viability of fondaparinux in this setting.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!